We have been developing an optical mammography prototype consisting of a multi-channel time-resolved spectroscopy system for breast cancer screening. The system utilizes the time-correlated single photon counting method, and the detector modules and the signal processing circuits were custom-made to obtain a high signal to noise ratio and high temperature stability with a high temporal resolution. Pulsed light generated by a Ti: Sapphire laser was irradiated to the breast, and the transmitted light was collected by optical fibers placed on the surface of a hemispherical gantry filled with an optical matching fluid. To reconstruct a 3D image of the breast, we employed a method using a time-resolved photon path distribution based on the assumption that scattering and absorption are independent of each other. We verified the possibility of human breast imaging by using a three-dimensional phantom model, which provides a simulation of human breast cancer, in the gantry. The clinical study was also started in January 2007. In a comparative study with conventional modalities, the breast cancers were detected as regions of optically higher absorption. Moreover, the results suggest that optical mammography is useful in monitoring the effects of chemotherapy.
Three-dimensional imaging of three small absorbers embedded in a tissuelike cylindrical solid phantom was conducted by diffusion optical tomography. Each absorber, which was 10 mm in diameter and 10 mm high, was located on the same plane in a phantom, which was 80 mm in diameter and 140 mm high. The optical properties of the phantom were similar to those of the human breast; that is, one absorber had lower absorption and the other two absorbers had higher absorption than that of the phantom. Reemission from the phantom was measured with a multichannel photon counting system. Image reconstruction was performed by our average value method. We were able to distinguish lower and higher absorbers quantitatively. This result shows that our method can diagnose not only the existence of but also a morbid state of breast cancer.
We previously compared time-domain diffuse optical spectroscopy (TD-DOS) with magnetic resonance imaging (MRI) using various water/lipid phantoms. However, it is difficult to conduct similar comparisons in the breast, because of measurement differences due to modality-dependent differences in posture. Dual-energy computed tomography (DECT) examination is performed in the same supine position as a TD-DOS measurement. Therefore, we first verified the accuracy of the measured fat fraction of fibroglandular tissue in the normal breast on DECT by comparing it with MRI in breast cancer patients (n = 28). Then, we compared lipid and water signals obtained in TD-DOS and DECT from normal and tumor-tissue regions (n = 16). The TD-DOS breast measurements were carried out using reflectance geometry with a source–detector separation of 3 cm. A semicircular region of interest (ROI), with a transverse diameter of 3 cm and a depth of 2 cm that included the breast surface, was set on the DECT image. Although the measurement area differed between the modalities, the correlation coefficients of lipid and water signals between TD-DOS and DECT were rs = 0.58 (p < 0.01) and rs = 0.90 (p < 0.01), respectively. These results indicate that TD-DOS captures the characteristics of the lipid and water contents of the breast.
Diffuse optical spectroscopy (DOS) is an emerging modality being researched for the examination of breast tissue and diagnosis of breast cancer.1–4 DOS enables quantitative measurements of oxygenated and deoxygenated hemoglobin concentrations, which are directly related to tumor angiogenesis.5